Home › Anemia
Anemia clinical trials recruiting in the U.S.
29 studies for Anemia are recruiting participants at sites across the United States.
Anemia occurs when your blood doesn't carry enough oxygen to the rest of your body. Read about conditions that lead to it and treatments available.
Cities with the most studies
- New York City, NY10 studies
- Miami, FL6 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- Atlanta, GA5 studies
- Winston-Salem, NC5 studies
- Tampa, FL5 studies
- St. Louis, MO4 studies
- Queens, NY4 studies
- Cleveland, OH4 studies
- Baldwin Park, CA4 studies
- Edison, NJ3 studies
- Orlando, FL3 studies
- Seattle, WA3 studies
- Portland, OR3 studies
- Nashville, TN3 studies
- The Woodlands, TX3 studies
- Kansas City, MO3 studies
- Washington, DC3 studies
- Gilbert, AZ3 studies
- Los Angeles, CA3 studies
By state
- Arizona4 studies
- California8 studies
- Florida9 studies
- Georgia6 studies
- Illinois3 studies
- Maryland3 studies
- Minnesota4 studies
- Missouri6 studies
- New Jersey3 studies
- New York12 studies
- North Carolina6 studies
- Ohio6 studies
- Oregon3 studies
- Pennsylvania7 studies
- Tennessee4 studies
- Texas8 studies
- Washington4 studies
Recently updated studies
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT06499285A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07623161A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07422480Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07224360Selinexor and Pacritinib in JAK Inhibitor-naïve MF Patients With Cytopenias
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT07447817Treating Anemia in Myelofibrosis With Repurposed Drugs (Nelfinavir) That Restore Iron Delivery to the Bone Marrow
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT07281781Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT05320198Therapeutic RSK1 Targeting in Myeloid Malignancies
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 21, 2026 · NCT07379125A Study of Luspatercept in People With Anemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT07725497Study of DISC-0974-201 in Participants With IBD and Anemia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07368972A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders
RecruitingObservational study
1 Month – 100 Years · All sexes · Updated Aug 19, 2026 · NCT06092346T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
RecruitingPhase 1/2
Ages 5 to 40 · All sexes · Updated Aug 13, 2026 · NCT03653338Study to Assess the Pharmacokinetics, Safety, and Tolerability of Iptacopan in Pediatric PNH Patients
RecruitingPhase 3
Ages 2 to 18 · All sexes · Updated Aug 7, 2026 · NCT06934967Choline and Iron Deficiency
RecruitingPhase 2/3
5 Months – 7 Months · All sexes · Updated Aug 5, 2026 · NCT06527391Kids With Iron Deficiency and Scoliosis
RecruitingHealthy volunteers welcome
Ages 10 to 26 · All sexes · Updated Jun 26, 2026 · NCT06042699Outcomes and Quality of Life Following Rectal Artery Embolization for Bleeding Internal Hemorrhoids
RecruitingObservational study
Ages 18 to 90 · All sexes · Updated Jun 17, 2026 · NCT06106269131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
RecruitingPhase 1
Ages 12 to 50 · All sexes · Updated Jun 10, 2026 · NCT07015684Darbe Plus IV Iron to Decrease Transfusions While Maintaining Iron Sufficiency in Preterm Infants
RecruitingPhase 2
3 Days · All sexes · Updated May 26, 2026 · NCT05340465Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 22, 2026 · NCT05800600A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Apr 17, 2026 · NCT03893045Diamond Blackfan Anemia Registry (DBAR)
RecruitingObservational study
All ages · All sexes · Updated Apr 16, 2026 · NCT00106015Luspatercept for Clonal Cytopenias of Uncertain Significance
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 24, 2026 · NCT06788691The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated Feb 6, 2026 · NCT06606119129Xe MRI Cardiopulmonary
RecruitingPhase 2Healthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT06038630A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
Recruiting
Ages 18 and older · All sexes · Updated Dec 30, 2025 · NCT05735314From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.